On August 24, 2009
The Teva-Shire Deal Worst-Case Scenario
The rumors that Teva might attempt to buy Shire are puzzling because such an acquisition would present a huge internal conflict to the combined company: What to do with Shire’s Vyvanse and Adderall XR brands, which are in direct competition with Teva’s generic Adderall pills?
0 Comments